TERAIMMUNE

WIPO WIPO 2020

Schützen Sie diese Marke vor Nachahmern!

Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.

Die Internationale Marke TERAIMMUNE wurde als Wortmarke am 21.09.2020 bei der Weltorganisation für geistiges Eigentum angemeldet.

Markendetails Letztes Update: 29. Juli 2022

Markenform Wortmarke
Aktenzeichen 1577553
Länder Schweiz China Europäische Gemeinschaft Großbritannien Japan Südkorea
Basismarke US Nr. 90175249, 11. September 2020
Anmeldedatum 21. September 2020
Ablaufdatum 21. September 2030

Markeninhaber

704 Quince Orchard Rd., Suite 160
Gaithersburg MD 20878
US

Markenvertreter

379 Lytton Avenue Palo Alto CA 94301 US

Waren und Dienstleistungen

05 Pharmaceutical preparations for the treatment of autoimmune diseases and conditions; pharmaceutical preparations for the treatment of hemophilia; pharmaceutical preparations for the treatment of cancer and tumors; pharmaceutical preparations for the treatment of multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; pharmaceutical preparations for use in immunotherapy, namely, regulatory t-cell therapy
40 Custom manufacturing services for pharmaceutical products; providing technical information in the field of pharmaceutical manufacturing; custom manufacturing of pharmaceuticals
42 Medical and pharmaceutical research and development services; scientific research and development services in the medical field; providing medical and scientific information in the medical field; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; scientific research and development services in the field of regulatory t-cell and chimeric antigen receptor therapy; scientific research and development services in the field of new cancer therapies; medical and veterinary research services, namely, the manipulation of cells within a laboratory or research facility to enable the cells to be used for therapeutic purposes; scientific research in human and animal gene therapy; scientific research into vectors and preparations for manipulating and adapting human and animal cells; consultancy relating to all the aforesaid services
44 Providing medical information in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; providing information in the medical field and in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation; consulting in the field of pharmaceuticals, autoimmune diseases and conditions, hemophilia, cancer, multiple sclerosis, atopic dermatitis, anti-drug antibody formation and xenotransplantation via a website; medical services; veterinary services; medical services in the extraction of human and animal cells from patients; manipulation of human and animal cells for therapeutic purposes; reinsertion of cells into human and animal patients for medical purposes; providing medical and therapy advice and consultancy in the field of medical and veterinary therapies; providing cancer therapy advice and consultancy; providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen

Markenhistorie

Datum Belegnummer Bereich Eintrag
08. Juli 2022 2022/29 Gaz CH RAW: Rule 18ter(2)(ii) GP following a provisional refusal
19. Mai 2022 2022/21 Gaz JP RAW: Rule 18ter(2)(ii) GP following a provisional refusal
08. März 2022 2022/10 Gaz KR Ablehnung
18. Februar 2022 2022/9 Gaz CH Ablehnung
07. Januar 2022 2022/2 Gaz JP Ablehnung
14. Juli 2021 2021/28 Gaz EM Ablehnung
21. Juni 2021 2021/29 Gaz CN Ablehnung
21. September 2020 2021/6 Gaz US Eintragung

ID: 141577553